氧化三甲胺与心血管疾病研究进展

郑佳; 徐昕; 郑黎强

doi:10.13201/j.issn.1001-1439.2017.11.023

氧化三甲胺与心血管疾病研究进展

- 1 中国医科大学附属盛京医院临床流行病学教研室(沈阳, 110004);
- 2 中国医科大学附属盛京医院图书馆, 临床流行病学教研室

详细信息

通讯作者: 郑黎强, E-mail:zhenglq@sj-hospital.org

中图分类号: R541

收稿日期: 2017-07-23

Advances in research on trimethylamine oxide with cardiovascular disease

- 1 Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, 110004, China;
- 2 Department of Clinical Epidemiology, Library, Shengjing Hospital of China Medical University

More Information

Corresponding author: ZHENG Liqiang, E-mail: zhenglq@sj-hospital.org

Received Date: 23 July 2017

摘要

摘要: 近些年来, 在控制传统危险因素的基础上中国居民心脑血管疾病的患病率与病死率仍处于上升阶段, 因此探究新的心脑血管疾病影响因素尤其分子生物学标志物已成为研究热点。有研究表明肠道菌群代谢物氧化三甲胺的血浆水平升高具有促进心脑血管疾病发生与发展的作用。在高血压、冠心病、心衰、脑卒中患者中血浆氧化三甲胺水平明显升高, 且对心脑血管疾病患者发生不良事件有预测价值。其主要致病机制为:促进动脉粥样硬化的发生发展, 促进血栓形成。目前对于氧化三甲胺的研究主要局限于动物和特殊人群 (患心脑血管疾病患者) 中, 未来应扩大研究对象在多中心、一般人群中研究验证。
- 氧化三甲胺 /
- 心血管疾病 /
- 动脉粥样硬化 /
- 血栓
Abstract: In recent years, based on the control of traditional risk factors, the prevalence and mortality of cardiovascular diseases in Chinese residents are still in the rising stage, so the study of new cardiovascular disease factors, especially molecular biology markers has become a hot topic.Studies have shown that intestinal microbial metabolite oxidation of trimethylamine plasma levels have increased the development of the cardiovascular disease.In patients with hypertension, coronary heart disease, heart failure, stroke, plasma levels of trimethylamine were significantly increased, and cardiovascular disease in patients with adverse events have predictive value.The main pathogenesis is to promote the occurrence and development of atherosclerosis and promote thrombosis.At present, the study of trimethylamine is mainly confined to animals and special populations (patients suffering from cardiovascular and cerebrovascular diseases).The future should be expanded in the multi-center, the general population in the study and verification.
- trimethylamine oxide /
- cardiovascular disease /
- atherosclerosism /
- thrombus

HTML全文

参考文献(32)

[1]	国家心血管病中心.中国心血管病报告2015[M].北京:中国大百科全书出版社, 2016:11-12.
[2]	LIBBY P, RIDKER P M, HANSSON G K.Progress and challenges in translating the biology of atherosclerosis.[J].Nature, 2011, 473:317-325.
[3]	ZHU W, GREGORY J C, ORG E, et al.Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.[J].Cell, 2016, 165:111-124.
[4]	TANG W H.Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease[J].Circ Res, 2015, 116:448-455.
[5]	YANCEY P H.Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses.[J].J Exp Biol, 2005, 208:2819-2830.
[6]	UFNAL M, JAZWIEC R, DADLEZ M, et al.Trimethylamine-N-Oxide:A Carnitine-Derived Metabolite That Prolongs the Hypertensive Effect of Angiotensin II in Rats.[J].Can J Cardiol, 2014, 30:1700-1705.
[7]	王珊, 夏耿红, 何彦, 等.氧化三甲胺分布特征及其与肠道菌群的关联性[J].南方医科大学学报, 2016, 36 (4):455-456.
[8]	WANG Z, ELIZABETH K, BENNETT B J, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J].Nature, 2011, 472:57-63.
[9]	KAYSEN G A, JOHANSEN K L, CHERTOW GM, et al.Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis[J].J Ren Nutr, 2015, 25:351-356.
[10]	TANG W H.Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J].N Engl JM ed, 2013, 368:1575-1584.
[11]	WANG Z, ELIZABETH K, BENNETT B J, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J].Nature, 2011, 472:57-63.
[12]	TANG W H, WANG Z, LEVISON B S.Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk[J].N Engl J Med, 2013, 368:1575-1584.
[13]	金华, 金钊, 张蕾蕾.肠道菌群可能为高血压发病的环境因素[J].中国微生态学杂志, 2015, 27 (1):121-124.
[14]	KOETH R A, WANG Z, LEVISON B S, et al.Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.[J].Nature Medicine, 2013, 19:576-585.
[15]	BENNETT B J, TQ D A V, WANG Z, et al.Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation[J].Cell Metabolism, 2013, 17:49-60.
[16]	FERRARIO C M.Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research[J].J Renin Angiotensin Aldosterone Syst, 2006, 7:3-14.
[17]	TOUYZ R M, CHEN X, TABET F, et al.Expression of a functionally active gp91phox-containing neutrophil-type NAD (P) H oxidase in smooth muscle cells from human resistance arteries:regulation by angiotensin II.[J].Circ Res, 2002, 90:1205-1213.
[18]	UFNAL M, JAZWIEC R, DADLEZ M, et al.Trimethylamine-N-Oxide:a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin IIin rats[J].Can J Cardiol, 2014, 30:1700-1705.
[19]	STUBBS J R, HOUSE J A, OCQUE A J, et al.Serum Trimethylamine-N-Oxide is elevated in CKD and correlates with coronary atherosclerosis burden[J].JAm Soc Nephrol, 2016, 27:305-313.
[20]	SENTHONG V, LI X S, HUDEC T, et al.Plasma Trimethylamine N-Oxide, a gut microbe-generated phosphatidylcholine metabolite, is associated with atherosclerotic burden[J].J Am Coll Cardiol, 2016, 67:2620-2628.
[21]	SENTHONG V, WANG Z, LI X S, et al.Intestinal Microbiota-generated metabolite trimethylamine-N-Oxide and 5-year mortality risk in stable coronary artery disease:the contributory role of intestinal microbiota in a COURAGE-like patient cohort[J].J Am Heart Assoc, 2016, 5:e002816.
[22]	MAFUNE A, IWAMOTO T, TSUTSUMI Y, et al.Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery:a cross-sectional study[J].Clin Exp Nephrol, 2016, 20:731-739.
[23]	TRØSEID M, UELAND T, HOV J R, et al.Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.[J].J Intern Med, 2014, 277:717-726.
[24]	TANG W H W, WANG Z, FAN Y, et al.Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-Oxide in patients with heart failure:refining the gut hypothesis[J].JAm Coll Cardiol, 2014, 61:1908-1914.
[25]	ORGAN C L, OTSUKA H, BHUSHAN S, et al.Choline diet and its gut microbe-derived metabolite, Trimethylamine N-Oxide, exacerbate pressure overload-induced heart failure[J].Circ Heart Fail, 2016, 9:e002314.
[26]	JIA Y, LIAO S, YAN H, et al.Dysbiosis of gut microbiota with reduced trimethylamine-N-Oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack[J].J Am Heart Assoc, 2015, 4:e002699.
[27]	LI X S, OBEID S, KLINGENBERG R, et al.Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes:aprognostic marker for incident cardiovascular events beyond traditional risk factors[J].Eur Heart J, 2017, 38:814-824.
[28]	JIA Y, LIAO S, YAN H, et al.Dysbiosis of gut microbiota with reduced trimethylamine-N-Oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack[J].J Am Heart Assoc, 2015, 4:e002699.
[29]	FEBBRAIO M, PODREZ E A, SMITH J D, et al.Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.[J].J Clin Invest, 2000, 105:1049-1056.
[30]	WANG Z, ELIZABETH K, BENNETT B J, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J].Nature, 2011, 472:57-63.
[31]	TANTRY U S, BONELLO L, ARADI D, et al.Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.[J].J Am Coll Cardiol, 2013, 62:2261-2273.
[32]	MA G, PAN B, CHEN Y, et al.Trimethylamine N-oxide in atherogenesis:impairing endothelial Self-repair capacity and enhancing monocyte adhesion[J].Biosci Rep, 2017, 37:111-115.